Further evidence for the existence of a specific process for the membrane transport of anandamide.
about
The endocannabinoid system as a target for the treatment of cannabis dependenceExploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporterFatty acid amide hydrolase inhibitors: a patent review (2009-2014)Identification of a high-affinity binding site involved in the transport of endocannabinoids.Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus.Pitfalls and solutions in assaying anandamide transport in cellsAnandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisInvolvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study.Role of the endogenous cannabinoid system in nicotine addiction: novel insights.A catalytically silent FAAH-1 variant drives anandamide transport in neurons.A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons.Endovanilloids are potential activators of the trigeminovascular nocisensor complexThe anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.Evidence for bidirectional endocannabinoid transport across cell membranesRetrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamideThe cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.Aspects of endocannabinoid signaling in periimplantation biologyExamination of the Addictive and Behavioral Properties of Fatty Acid-Binding Protein Inhibitor SBFI26.Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer painEndocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity.Targeting the endocannabinoid system: to enhance or reduce?Endocannabinoid-mediated control of synaptic transmission.Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus)Transport of endocannabinoids across the plasma membrane and within the cell.Is there a temperature-dependent uptake of anandamide into cells?Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation.The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrateParadoxical effects of the endocannabinoid uptake inhibitor VDM11 on accumbal neural encoding of reward predictive cues.Membrane transport of anandamide through resealed human red blood cell membranes.Synthesis of a photoactivatable probe of the anandamide re-uptake.Effect of an unstirred layer on the membrane permeability of anandamide.Cannabinoid modulation of electrically evoked pH and oxygen transients in the nucleus accumbens of awake rats.Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamates.
P2860
Q24648135-082D2675-A1C0-48C1-BA21-B296017DB8C0Q27330950-E5C964F4-95F9-48DF-A81C-26D4366230A6Q28267884-6B4AC81C-6395-42B2-8376-C7F68B97852DQ28284073-8232D1D9-90A9-4C55-AD70-EAF13A94B2D3Q30463112-AE250C4B-3659-4244-83E5-61E2C15F5C12Q33993270-15FE9E9D-D8B0-41F6-87F8-12EB2DD4635FQ34491915-8EBC06F0-92DE-4900-8D10-2454751A078DQ34625932-F2F01999-B555-495F-9745-9C3660EED5F5Q34818110-3F5B890C-0840-462E-A07B-127511D519B5Q35098586-BFA4F2E8-6EA3-4DAF-B4B7-594FBCBFB6FCQ35216071-6C4AC9C1-8CBF-490A-B562-144C2B612D49Q35216481-96C26933-64F4-4469-9982-4D085C141CD5Q35633097-8B423712-5F5E-49F5-AD95-E70330A1A2A9Q35843085-C392E770-D557-4AF5-B1D0-05BD0F48536FQ36020582-4D015C8C-51DE-4C52-A5CA-7406AB05C31EQ36176513-E88DD908-421B-49F2-B1EF-816FA6130023Q36298487-D59E26AB-5803-4B64-8693-111DF5190A50Q36300113-327D103B-194F-48FB-85B9-FC4685E74651Q36439202-8B7F98B9-9B2C-4C44-B46D-753D3EE9D60DQ36655240-03494E6B-9270-4587-9469-B43C0C235EEBQ36731481-549C5891-C651-4B79-BC77-30605EAE5D97Q36764791-1DBB53B2-73E7-4EAE-AD3B-9F017C86DF79Q36912778-729676EB-CEE0-4287-9192-A822C132299AQ37107118-6A5B6C4D-1942-435A-907B-473231ADA3CFQ37140712-71913C2C-D8CB-4057-BEE8-FD88DD3EAAA3Q37150745-DFABF8AC-E7D5-42E9-9AAF-BBC46E5D1A9EQ37363621-079FE02E-452D-422F-81F8-F5246CD58553Q37630381-0A81E713-9F8B-4B43-BD60-93FB283E2508Q38084704-12C77919-EC07-4A06-B6DD-BA4D2C14DB4FQ38961198-DE3A4845-D3D5-4DF4-85B2-376B1E29DB08Q40006174-E2C21767-24BE-4759-964F-4E94BC922887Q40166022-0BE013CC-39F0-4943-9ECF-E60F63A7E20AQ40245489-194E1D8A-79F9-40EB-8F72-9CB6B497FFB5Q42034486-462C2B7A-0FE3-4E56-BC4E-43F438BD6521Q43084633-A3F6F304-4CC0-4883-96BB-47F2CC8F25E5Q46522893-372E800F-A388-4909-A343-3E920233FBB1Q46529908-FC410D9E-5E95-4207-8629-F7B73A182032Q46859636-56690984-85EF-4DE2-8F7F-CC31187BC863Q48547114-97904778-316E-48D8-8B97-7EDA29A6FC2CQ52141091-26658593-2589-41E1-95CF-CD06C44277C2
P2860
Further evidence for the existence of a specific process for the membrane transport of anandamide.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Further evidence for the exist ...... brane transport of anandamide.
@en
type
label
Further evidence for the exist ...... brane transport of anandamide.
@en
prefLabel
Further evidence for the exist ...... brane transport of anandamide.
@en
P2093
P2860
P356
P1433
P1476
Further evidence for the exist ...... brane transport of anandamide.
@en
P2093
Alessia Ligresti
Giorgio Ortar
Krisztina Monory
Mario Van Der Stelt
P2860
P304
P356
10.1042/BJ20031812
P407
P577
2004-05-01T00:00:00Z